Prosecution Insights
Last updated: April 19, 2026

Shanghai Hep Pharmaceutical Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18296454 COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES TSAY, MARSHA M 1656 Final Rejection Apr 06, 2023
16759200 Drug and Method for Treating Liver Diseases Related to Hepatitis B Viruses in Full-Dose Condition COFFA, SERGIO 1658 Final Rejection Apr 24, 2020

Managing Shanghai Hep Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month